Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study
This article aims to assess the factors associated with non-response to treatment
Abstract
Sikkim, India, has the highest proportion of tuberculosis (TB) patients on first-line anti-tuberculosis regimens with the outcome ‘failure’ or ‘shifted to regimen for multidrug-resistant TB (MDR-TB)’. This article aims to assess the factors associated with non-response to treatment, i.e., ‘failure’ or ‘shifted to MDR-TB regimen’.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Singhi L, Sagili KD, Sharath BN, Bhandari K, Dadul PK, Gautam M, Ravichandra C, Chadha S, Satyanarayana S. Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study. Public Health Action. 2018 Dec 21;8(4):162–8.